577 related articles for article (PubMed ID: 15720902)
1. The role of percutaneous nephrostomy in malignant ureteric obstruction.
Wilson JR; Urwin GH; Stower MJ
Ann R Coll Surg Engl; 2005 Jan; 87(1):21-4. PubMed ID: 15720902
[TBL] [Abstract][Full Text] [Related]
2. Percutaneous nephrostomy versus indwelling ureteral stents in the management of extrinsic ureteral obstruction in advanced malignancies: are there differences?
Ku JH; Lee SW; Jeon HG; Kim HH; Oh SJ
Urology; 2004 Nov; 64(5):895-9. PubMed ID: 15533473
[TBL] [Abstract][Full Text] [Related]
3. Ureteric stents vs percutaneous nephrostomy for initial urinary drainage in children with obstructive anuria and acute renal failure due to ureteric calculi: a prospective, randomised study.
ElSheemy MS; Shouman AM; Shoukry AI; ElShenoufy A; Aboulela W; Daw K; Hussein AA; Morsi HA; Badawy H
BJU Int; 2015 Mar; 115(3):473-9. PubMed ID: 24698195
[TBL] [Abstract][Full Text] [Related]
4. Prognostic model for predicting survival after palliative urinary diversion for ureteral obstruction: analysis of 140 cases.
Ishioka J; Kageyama Y; Inoue M; Higashi Y; Kihara K
J Urol; 2008 Aug; 180(2):618-21; discussion 621. PubMed ID: 18554655
[TBL] [Abstract][Full Text] [Related]
5. Percutaneous urinary drainage and ureteric stenting in malignant disease.
Allen DJ; Longhorn SE; Philp T; Smith RD; Choong S
Clin Oncol (R Coll Radiol); 2010 Nov; 22(9):733-9. PubMed ID: 20728326
[TBL] [Abstract][Full Text] [Related]
6. Role of percutaneous nephrostomy (PCN) in malignant ureteral obstruction.
Jalbani MH; Deenari RA; Dholia KR; Oad AK; Arbani IA
J Pak Med Assoc; 2010 Apr; 60(4):280-3. PubMed ID: 20419970
[TBL] [Abstract][Full Text] [Related]
7. [Percutaneous drainage nephrostomy in patients over 70 years of age. Apropos of 98 nephrostomies in 74 patients].
Fournier G; Delavierre D; Le Coat R; Philippe P; Mangin P
Prog Urol; 1994 Jun; 4(3):362-70. PubMed ID: 8044179
[TBL] [Abstract][Full Text] [Related]
8. The management of malignant ureteral obstruction treated with ureteral stents.
Ganatra AM; Loughlin KR
J Urol; 2005 Dec; 174(6):2125-8. PubMed ID: 16280741
[TBL] [Abstract][Full Text] [Related]
9. Use of nephrostomy tubes in ureteric obstruction from incurable malignancy.
Little B; Ho KJ; Gawley S; Young M
Int J Clin Pract; 2003 Apr; 57(3):180-1. PubMed ID: 12723719
[TBL] [Abstract][Full Text] [Related]
10. A prognostic model for survival after palliative urinary diversion for malignant ureteric obstruction: a prospective study of 208 patients.
Cordeiro MD; Coelho RF; Chade DC; Pessoa RR; Chaib MS; Colombo-Júnior JR; Pontes-Júnior J; Guglielmetti GB; Srougi M
BJU Int; 2016 Feb; 117(2):266-71. PubMed ID: 25327474
[TBL] [Abstract][Full Text] [Related]
11. The outcome with ureteric stents for managing non-urological malignant ureteric obstruction.
Jeong IG; Han KS; Joung JY; Seo HK; Chung J
BJU Int; 2007 Dec; 100(6):1288-91. PubMed ID: 17850371
[TBL] [Abstract][Full Text] [Related]
12. [Endoluminal therapy for bilateral malignant ureteric obstruction].
Liu YD; Yuan J; Huang ST; Luo JT; Zeng GH; Xun L
Zhonghua Zhong Liu Za Zhi; 2007 Sep; 29(9):717-9. PubMed ID: 18246808
[TBL] [Abstract][Full Text] [Related]
13. Management of ureteral obstruction due to advanced malignancy: optimizing therapeutic and palliative outcomes.
Kouba E; Wallen EM; Pruthi RS
J Urol; 2008 Aug; 180(2):444-50. PubMed ID: 18550089
[TBL] [Abstract][Full Text] [Related]
14. [Relief of upper urinary tract obstruction in patients with cancer of the prostate].
Kraemer PC; Borre M
Ugeskr Laeger; 2009 Mar; 171(11):873-6. PubMed ID: 19278608
[TBL] [Abstract][Full Text] [Related]
15. Palliative Subcutaneous Tunneled Nephrostomy Tube (PSTN): a simple and effective technique for management of malignant extrinsic ureteral obstruction.
Bell DG; Fischer MA
Can J Urol; 2002 Feb; 9(1):1470-4. PubMed ID: 11886602
[TBL] [Abstract][Full Text] [Related]
16. Percutaneous nephrostomy for ureteric obstruction due to advanced pelvic malignancy: have we got the balance right?
Misra S; Coker C; Richenberg J
Int Urol Nephrol; 2013 Jun; 45(3):627-32. PubMed ID: 23666587
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors in malignant ureteric obstruction.
Lienert A; Ing A; Mark S
BJU Int; 2009 Oct; 104(7):938-41. PubMed ID: 19338533
[TBL] [Abstract][Full Text] [Related]
18. Nephrostomy insertion for patients with bilateral ureteric obstruction caused by prostate cancer.
Nariculam J; Murphy DG; Jenner C; Sellars N; Gwyther S; Gordon SG; Swinn MJ
Br J Radiol; 2009 Jul; 82(979):571-6. PubMed ID: 19153185
[TBL] [Abstract][Full Text] [Related]
19. Current status of metal stents for managing malignant ureteric obstruction.
Sountoulides P; Kaplan A; Kaufmann OG; Sofikitis N
BJU Int; 2010 Apr; 105(8):1066-72. PubMed ID: 20067458
[TBL] [Abstract][Full Text] [Related]
20. [Palliative diversion using an autostatic ureteral stent after endoscopic resection of the ureteral meatus in T4 pelvic tumors].
Flam T; Géraud M; Zerbib M; Debré B; Steg A
Ann Urol (Paris); 1990; 24(6):530-2. PubMed ID: 1702963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
